Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation
Scandinavian journal of gastroenterology, 2018, Pages 1-8.
DAADirect Acting AntiviralsHCVbarriers to treatmentfactors associated with treatmentMore(4+)
In this nationwide cohort study, we found non-adherence to medical appointments and active substance use to be major obstacles for DAA treatment initiation. Our findings highlight the need for interventions that can overcome these barriers and increase the number of patients who can initiate and benefit from curative DAA treatment.
Full Text (Upload PDF)